These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8215968)

  • 1. Vascular amyloid deposition in Alzheimer's disease. Neither necessary nor sufficient for the local formation of plaques or tangles.
    Lippa CF; Hamos JE; Smith TW; Pulaski-Salo D; Drachman DA
    Arch Neurol; 1993 Oct; 50(10):1088-92. PubMed ID: 8215968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease.
    Arriagada PV; Growdon JH; Hedley-Whyte ET; Hyman BT
    Neurology; 1992 Mar; 42(3 Pt 1):631-9. PubMed ID: 1549228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.
    Nagy Z; Esiri MM; Jobst KA; Morris JH; King EM; McDonald B; Litchfield S; Smith A; Barnetson L; Smith AD
    Dementia; 1995; 6(1):21-31. PubMed ID: 7728216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia characterized by abundant neurofibrillary tangles and scarce senile plaques: a quantitative pathological study.
    Itoh ; Yamada M; Yoshida R; Suematsu N; Oka T; Matsushita M; Otomo E
    Eur Neurol; 1996; 36(2):94-7. PubMed ID: 8654493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease.
    Namba Y; Tsuchiya H; Ikeda K
    Neurosci Lett; 1992 Jan; 134(2):264-6. PubMed ID: 1375354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.
    Arriagada PV; Marzloff K; Hyman BT
    Neurology; 1992 Sep; 42(9):1681-8. PubMed ID: 1307688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.
    Price JL; Davis PB; Morris JC; White DL
    Neurobiol Aging; 1991; 12(4):295-312. PubMed ID: 1961359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
    Muramori F; Kobayashi K; Nakamura I
    Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase.
    Provias J; Jeynes B
    Curr Neurovasc Res; 2008 Aug; 5(3):199-205. PubMed ID: 18691078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition.
    Yamaguchi H; Ishiguro K; Sugihara S; Nakazato Y; Kawarabayashi T; Sun X; Hirai S
    Acta Neuropathol; 1994; 88(5):413-9. PubMed ID: 7847069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
    Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
    J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease.
    Lovell MA; Smith JL; Xiong S; Markesbery WR
    Neurotox Res; 2005; 7(4):265-71. PubMed ID: 16179263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: the relationship between the density of senile plaques, neurofibrillary tangles and A4 protein in human patients.
    Armstrong RA; Myers D; Smith CU; Cairns N; Luthert PJ
    Neurosci Lett; 1991 Feb; 123(2):141-3. PubMed ID: 1709265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls.
    Savioz A; Giannakopoulos P; Herrmann FR; Klein WL; Kövari E; Bouras C; Giacobini E
    Neurodegener Dis; 2016; 16(5-6):398-406. PubMed ID: 27400224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.
    Bierer LM; Hof PR; Purohit DP; Carlin L; Schmeidler J; Davis KL; Perl DP
    Arch Neurol; 1995 Jan; 52(1):81-8. PubMed ID: 7826280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative differences in the deposition of beta A4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's disease.
    Gentleman SM; Allsop D; Bruton CJ; Jagoe R; Polak JM; Roberts GW
    Neurosci Lett; 1992 Feb; 136(1):27-30. PubMed ID: 1635663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
    Jeynes B; Provias J
    Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged.
    Ii K; Ito H; Kominami E; Hirano A
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(3):185-94. PubMed ID: 8236812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.